Alpha Emitter Global Market Report 2026

Description

An alpha emitter is a form of radioactive material that releases alpha particles during radioactive decay. It includes elements such as uranium, radium, and plutonium, which undergo alpha decay as part of natural radioactive processes. Alpha emitters are important in medical treatments, particularly cancer therapy, and have applications in technologies like smoke detectors and space exploration.

The main radionuclides of alpha emitters include radium, actinium, lead, bismuth, and others. Radium is a radioactive substance used in both therapeutic and diagnostic medical procedures. The sources include natural origins, artificially produced sources, and others, while the applications include pancreatic cancer, ovarian cancer, prostate cancer, lymphoma, melanoma, bone metastasis, and others. They are used across various end-users such as hospitals, medical research organizations, and others.

Tariffs have influenced the alpha emitter market by increasing costs for imported radionuclides and production equipment, particularly affecting segments like radium-223, actinium-225, and bismuth-213. Asia-Pacific regions, including China and India, are highly impacted due to import dependencies. While tariffs raise production costs and may slow supply chains, they also incentivize local production, research investment, and development of alternative radionuclide sources, supporting long-term market growth.

The alpha emitter market research report is one of a series of new reports from The Business Research Company that provides alpha emitter market statistics, including alpha emitter industry global market size, regional shares, competitors with a alpha emitter market share, detailed alpha emitter market segments, market trends and opportunities, and any further data you may need to thrive in the alpha emitter industry. This alpha emitter market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The alpha emitter market size has grown exponentially in recent years. It will grow from $1.61 billion in 2025 to $1.99 billion in 2026 at a compound annual growth rate (CAGR) of 23.6%. The growth in the historic period can be attributed to limited availability of alpha-emitting radionuclides, reliance on natural sources like uranium and radium, growing awareness of targeted cancer therapies, emergence of early clinical trials, limited production infrastructure.

The alpha emitter market size is expected to see exponential growth in the next few years. It will grow to $4.6 billion in 2030 at a compound annual growth rate (CAGR) of 23.3%. The growth in the forecast period can be attributed to development of artificial radionuclide production facilities, rising investment in oncology treatments, increasing adoption in bone metastasis and prostate cancer therapies, advancement in targeted alpha therapy technologies, expanding medical research applications. Major trends in the forecast period include rising adoption of alpha-emitter-based cancer therapies, increased research in radionuclide production and isolation, growth in artificially produced alpha emitters, expansion of therapeutic applications beyond oncology, enhanced focus on safety and regulatory compliance for handling radioactive materials.

The growing prevalence of cancer is expected to drive the growth of the alpha emitter market in the coming years. Cancer is a disease characterized by the uncontrolled proliferation and spread of abnormal cells within the body, which can form tumors and invade surrounding tissues. The increasing prevalence of cancer is influenced by factors such as aging populations, environmental exposure, lifestyle changes, and advancements in detection methods. Alpha emitters are used in cancer therapy to precisely target and destroy tumor cells while minimizing damage to nearby healthy tissues. For example, in February 2024, the World Health Organization, a Switzerland-based intergovernmental organization, projected that by 2050, there will be more than 35 million new cancer cases worldwide, representing a 77% increase compared with the estimated 20 million cases recorded in 2022. Therefore, the increasing prevalence of cancer is driving the growth of the alpha emitter market.

Companies operating in the alpha-emitter market are investing in innovative solutions, such as alpha-emitting radionuclides produced using cyclotrons, to strengthen their competitive positioning. Alpha-emitting radionuclides generated using cyclotrons are radioactive isotopes that emit alpha particles during decay, produced by accelerating charged particles to high energies within a cyclotron. For example, in April 2023, Ionetix, a US-based cyclotron and technology company, produced its first alpha-emitting radionuclide, Astatine-211 (At-211), at its newly established Alpha Isotope Manufacturing facility in Lansing, Michigan. This facility is notable for being the first in the US dedicated exclusively to producing alpha-emitting radionuclides using cyclotron technology. Production was achieved through the commissioning of a 30 MeV cyclotron designed to accelerate alpha particles for high-yield generation of At-211 and Actinium-225 (Ac-225).

In February 2024, Bristol-Myers Squibb Co. (BMS), a US-based biopharmaceutical company, acquired RayzeBio, Inc. for $4.1 billion. With this acquisition, Bristol-Myers Squibb Co. enhances its oncology portfolio by adding innovative radiopharmaceutical therapies, particularly targeted alpha-emitter treatments. RayzeBio Inc. is a US-based provider of alpha-emitter technologies.

Major companies operating in the alpha emitter market are Bayer AG, Lantheus Holdings Inc., Curium Pharma, Eckert & Ziegler BEBIG GmbH, Telix Pharmaceuticals Limited, NorthStar Medical Radioisotopes LLC, ITM Isotope Technologies Munich SE, International Isotopes Inc., IBA Radiopharma Solutions, Orano Med LLC, Actinium Pharmaceuticals Inc., Clarity Pharmaceuticals Ltd., RadioMedix Inc., Nordic Nanovector ASA, TAE Life Sciences, Fusion Pharmaceuticals Inc., Alpha Tau Medical Ltd., Alpha-9 Oncology, Aktis Oncology, Abdera Therapeutics, Oncoinvent ASA, Theragnostics Ltd., ARICEUM Therapeutics, Sirius Medical Systems B.V.

North America was the largest region in the alpha emitter market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the alpha emitter market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the alpha emitter market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The alpha emitter market consists of sales of Plutonium-238 (Pu-238), Thorium-227 (Th-227), Polonium-210 (Po-210), and Americium-241 (Am-241). Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Alpha Emitter Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses alpha emitter market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for alpha emitter ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The alpha emitter market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

Markets Covered:1) By Type Of Radionuclide: Radium; Actinium; Lead; Bismuth; Other Types Of Radionuclides
2) By Source: Natural Sources; Artificially Produced Sources; Other Sources
3) By Application: Pancreatic Cancer; Ovarian Cancer; Prostate Cancer; Lymphoma; Melanoma; Bone Metastasis; Other Applications
4) By End-User: Hospitals; Medical Research Institutions; Other End-Users
Subsegments:
1) By Radium: Radium-223; Radium-226; Radium-228
2) By Actinium: Actinium-227; Actinium-225
3) By Lead: Lead-210; Lead-212
4) By Bismuth: Bismuth-213; Bismuth-212
5) By Other Types of Radionuclides: Thorium; Polonium; Francium
Companies Mentioned: Bayer AG; Lantheus Holdings Inc.; Curium Pharma; Eckert & Ziegler BEBIG GmbH; Telix Pharmaceuticals Limited; NorthStar Medical Radioisotopes LLC; ITM Isotope Technologies Munich SE; International Isotopes Inc.; IBA Radiopharma Solutions; Orano Med LLC; Actinium Pharmaceuticals Inc.; Clarity Pharmaceuticals Ltd.; RadioMedix Inc.; Nordic Nanovector ASA; TAE Life Sciences; Fusion Pharmaceuticals Inc.; Alpha Tau Medical Ltd.; Alpha-9 Oncology; Aktis Oncology; Abdera Therapeutics; Oncoinvent ASA; Theragnostics Ltd.; ARICEUM Therapeutics; Sirius Medical Systems B.V.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Product Code: ME4MAEMI02_G26Q1

1. Executive Summary

1.1. Key Market Insights (2020-2035)
1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
1.3. Major Factors Driving the Market
1.4. Top Three Trends Shaping the Market

2. Alpha Emitter Market Characteristics

2.1. Market Definition & Scope
2.2. Market Segmentations
2.3. Overview of Key Products and Services
2.4. Global Alpha Emitter Market Attractiveness Scoring And Analysis
- 2.4.1. Overview of Market Attractiveness Framework
- 2.4.2. Quantitative Scoring Methodology
- 2.4.3. Factor-Wise Evaluation
Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation
2.4.5. Strategic Implications and Recommendations

3. Alpha Emitter Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem
3.2. List Of Key Raw Materials, Resources & Suppliers
3.3. List Of Major Distributors and Channel Partners
3.4. List Of Major End Users

4. Global Alpha Emitter Market Trends And Strategies

4.1. Key Technologies & Future Trends
- 4.1.1 Biotechnology, Genomics & Precision Medicine
- 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
- 4.1.3 Industry 4.0 & Intelligent Manufacturing
- 4.1.4 Sustainability, Climate Tech & Circular Economy
- 4.1.5 Artificial Intelligence & Autonomous Intelligence
4.2. Major Trends
- 4.2.1 Rising Adoption Of Alpha-Emitter-Based Cancer Therapies
- 4.2.2 Increased Research In Radionuclide Production And Isolation
- 4.2.3 Growth In Artificially Produced Alpha Emitters
- 4.2.4 Expansion Of Therapeutic Applications Beyond Oncology
- 4.2.5 Enhanced Focus On Safety And Regulatory Compliance For Handling Radioactive Materials

5. Alpha Emitter Market Analysis Of End Use Industries

5.1 Hospitals
5.2 Medical Research Institutions
5.3 Oncology Clinics
5.4 Pharmaceutical Companies
5.5 Nuclear Medicine Laboratories

6. Alpha Emitter Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Alpha Emitter Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Alpha Emitter PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Alpha Emitter Market Size, Comparisons And Growth Rate Analysis
7.3. Global Alpha Emitter Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Alpha Emitter Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Alpha Emitter Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Alpha Emitter Market Segmentation

9.1. Global Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Radium, Actinium, Lead, Bismuth, Other Types Of Radionuclides
9.2. Global Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Natural Sources, Artificially Produced Sources, Other Sources
9.3. Global Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Pancreatic Cancer, Ovarian Cancer, Prostate Cancer, Lymphoma, Melanoma, Bone Metastasis, Other Applications
9.4. Global Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospitals, Medical Research Institutions, Other End-Users
9.5. Global Alpha Emitter Market, Sub-Segmentation Of Radium, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Radium-223, Radium-226, Radium-228
9.6. Global Alpha Emitter Market, Sub-Segmentation Of Actinium, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Actinium-227, Actinium-225
9.7. Global Alpha Emitter Market, Sub-Segmentation Of Lead, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Lead-210, Lead-212
9.8. Global Alpha Emitter Market, Sub-Segmentation Of Bismuth, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Bismuth-213, Bismuth-212
9.9. Global Alpha Emitter Market, Sub-Segmentation Of Other Types Of Radionuclides, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Thorium, Polonium, Francium

10. Alpha Emitter Market Regional And Country Analysis

10.1. Global Alpha Emitter Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Alpha Emitter Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Alpha Emitter Market

11.1. Asia-Pacific Alpha Emitter Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Alpha Emitter Market

12.1. China Alpha Emitter Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Alpha Emitter Market

13.1. India Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Alpha Emitter Market

14.1. Japan Alpha Emitter Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Alpha Emitter Market

15.1. Australia Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Alpha Emitter Market

16.1. Indonesia Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Alpha Emitter Market

17.1. South Korea Alpha Emitter Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Alpha Emitter Market

18.1. Taiwan Alpha Emitter Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Alpha Emitter Market

19.1. South East Asia Alpha Emitter Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Alpha Emitter Market

20.1. Western Europe Alpha Emitter Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Alpha Emitter Market

21.1. UK Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Alpha Emitter Market

22.1. Germany Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Alpha Emitter Market

23.1. France Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Alpha Emitter Market

24.1. Italy Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Alpha Emitter Market

25.1. Spain Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Alpha Emitter Market

26.1. Eastern Europe Alpha Emitter Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Alpha Emitter Market

27.1. Russia Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Alpha Emitter Market

28.1. North America Alpha Emitter Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Alpha Emitter Market

29.1. USA Alpha Emitter Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Alpha Emitter Market

30.1. Canada Alpha Emitter Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Alpha Emitter Market

31.1. South America Alpha Emitter Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Alpha Emitter Market

32.1. Brazil Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Alpha Emitter Market

33.1. Middle East Alpha Emitter Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Alpha Emitter Market

34.1. Africa Alpha Emitter Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Alpha Emitter Market Regulatory and Investment Landscape

36. Alpha Emitter Market Competitive Landscape And Company Profiles

36.1. Alpha Emitter Market Competitive Landscape And Market Share 2024
- 36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Alpha Emitter Market - Company Scoring Matrix
- 36.2.1. Market Revenues
- 36.2.2. Product Innovation Score
- 36.2.3. Brand Recognition
36.3. Alpha Emitter Market Company Profiles
- 36.3.1. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 36.3.2. Lantheus Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.3. Curium Pharma Overview, Products and Services, Strategy and Financial Analysis
- 36.3.4. Eckert & Ziegler BEBIG GmbH Overview, Products and Services, Strategy and Financial Analysis
- 36.3.5. Telix Pharmaceuticals Limited Overview, Products and Services, Strategy and Financial Analysis

37. Alpha Emitter Market Other Major And Innovative Companies

NorthStar Medical Radioisotopes LLC, ITM Isotope Technologies Munich SE, International Isotopes Inc., IBA Radiopharma Solutions, Orano Med LLC, Actinium Pharmaceuticals Inc., Clarity Pharmaceuticals Ltd., RadioMedix Inc., Nordic Nanovector ASA, TAE Life Sciences, Fusion Pharmaceuticals Inc., Alpha Tau Medical Ltd., Alpha-9 Oncology, Aktis Oncology, Abdera Therapeutics

38. Global Alpha Emitter Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Alpha Emitter Market

40. Alpha Emitter Market High Potential Countries, Segments and Strategies

40.1 Alpha Emitter Market In 2030 - Countries Offering Most New Opportunities
40.2 Alpha Emitter Market In 2030 - Segments Offering Most New Opportunities
40.3 Alpha Emitter Market In 2030 - Growth Strategies
- 40.3.1 Market Trend Based Strategies
- 40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations
41.2. Currencies
41.3. Historic And Forecast Inflation Rates
41.4. Research Inquiries
41.5. The Business Research Company
41.6. Copyright And Disclaimer